Harrington Scholar-Innovator – LOI

Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit: Inquire within unit

Memorial Deadline: RIS review not required for LOI

External Deadline: Monday 5th, June 2023


Description

M.D. required for eligibility. Open to physician-scientists in the US and Canada.

Letters of Intent (LOI) Due: June 5, 2023

Harrington Discovery Institute invites you to submit a brief letter of intent (LOI) for the 2024 Harrington Scholar-Innovator Award. This grant supports all disease areas and is designed to advance promising drug discovery research towards the clinic. Up to 12 Scholar-Innovators will be selected to receive:

  • $100,000 guaranteed grant award;
  • Drug and business development support from Harrington’s Therapeutics Development Center advisors;
  • Opportunity to compete for acceleration funds up to $300,000;
  • Opportunity to quality for investment funds typically up to $2MM.

 

Pending how far an applicant makes it in the review process, Harrington Discovery Institute may be able to provide reviewers’ comments and feedback to help the applicant strengthen the proposal for future submission.

 

Visit Harrington Discovery Institute website to learn more about the Harrington Scholar-Innovator program.

To submit an LOI online, Visit the grant system link and create an account. 

Questions? Email Questions@HarringtonDiscovery.org.

 


Funding Sources

Harrington Discovery Institute



This opportunity was posted by: RGCS

Last modified: April 24, 2023